Replies to post #346989 on Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

If you can find something more recent, please post. I am fairly certain that fewer people are taking nifedipine now than 10 years ago. I am completely certain it is not a billion dollar drug- then, now, ever.

There appears two problems with that statement, as a quick search would discover. There are at least two links no older than 4-5 months that cite the following (more if you want to pay $3-5k for the in-depth report):

Nifedipine Market size is forecast to reach $1.37 billion by 2025

Posted on Jul 7 2020 11:58 AM

Here are the links...

https://icrowdnewswire.com/2020/07/23/nifedipine-market-size-forecast-to-reach-1-37-billion-by-2025/

https://www.theexpresswire.com/pressrelease/Nifedipine-Market-size-is-forecast-to-reach-137-billion-by-2025_11291546#:~:text=Nifedipine%20Market%20size%20is%20forecast%20to%20reach%20%241.37,is%20a%20calcium%20channel%20blocker%20of%20dihydropyridine%20type.

Since I am on a one-a-day regiment, allow me to add that I believe Elite will seek to commercialize solid dose tablets. Why? Glad to be asked...

The Nifedipine Controlled Release Tablet segment held the largest share in the Nifedipine Market in 2019 and is estimated to grow at a CAGR of 4.85% during the forecast period 2020-2025 owing to its use to treat angina and high blood pressure. Both the nifedipine immediate-release capsules and extended-release tablets are available as generic drugs. It helps to prevent strokes, heart attacks, and kidney problems. Tachycardia occur as a reaction when patients feel dizzy or faint after taking the first few doses of nifedipine controlled-release tablets. These problems are much less frequent within the sustained-release preparations of nifedipine. Nifedipine controlled-release tablet is used to treat severely high blood pressure in pregnancy and is sold under the brand name Adalat which is used to manage Raynaud’s phenomenon and premature labor. Nifedipine Controlled Release Tablet is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.

[rocioyogi]

Wee: Please your insight is always appreciated why do you attribute to the huge volume increase today what speculation or hit might you have thanks in advance